AMCP conducted a Market Insights roundtable to discuss the effect of COVID-19 on the healthcare payer and PBM systems from a population health management perspective. Due to emerging variants, the implications of Emergency Use Authorization versus full FDA approval, challenges with vaccination hesitancy, new treatments being identified and COVID-19 long haulers, AMCP members face challenges in navigating the dynamic landscape of COVID-19. This webinar will review the needs of healthcare decision makers, from the availability of vaccine data to options and projected costs of treatment to preferred partnerships with pharma.
President & Founder, Accountable Health, LLC
Instructor, John D. Bower School of Population Health, University of Mississippi Medical Center
Jay Weaver, PharmD, MPH
Vice President Pharmacy and Chief Pharmacy Officer
Blue Cross and Blue Shield of Kansas City